Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Desert Gold Report Results from 3,900 Meter Phase 2 Exploration Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pfizer Inc PFE

Alternate Symbol(s):  N.PFE

Healthcare
Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the... see more

Recent & Breaking News (NYSE:PFE)

Pfizer (PFE) will buy up Hospira in ~$15 billion deal

Canadian Press February 5, 2015

Pfizer Invites Investors, Analysts And Media To Join Conference Calls Discussing Pfizer's Proposed Acquisition of Hospira

Business Wire February 5, 2015

Pfizer To Acquire Hospira

Business Wire February 5, 2015

Pfizer Announces FDA Acceptance For Review Of Supplemental New Drug Application For Oral XELJANZ® (tofacitinib citrate) For Adult Patients With Moderate To Severe Chronic Plaque Psoriasis

Business Wire February 4, 2015

ViiV Healthcare Announces $10 Million Initiative to Accelerate Response to HIV/AIDS Among Black Gay and Bisexual Men

PR Newswire February 4, 2015

Pfizer Marks World Cancer Day with Grant to Union for International Cancer Control to Address the Needs of Metastatic Breast Cancer Patients

Business Wire February 4, 2015

Pfizer Receives U.S. FDA Accelerated Approval of IBRANCE® (palbociclib)

Business Wire February 3, 2015

OPKO and Pfizer Receive Regulatory Clearance for Global Agreement

Business Wire January 29, 2015

PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2014 RESULTS; PROVIDES 2015 FINANCIAL GUIDANCE

Business Wire January 27, 2015

Pfizer Commits to Further Reduce Price for Prevenar 13 in the World's Poorest Countries Through 2025

Business Wire January 26, 2015

Prevenar 13®* Receives CHMP Positive Opinion For Prevention Of Vaccine-Type Pneumococcal Pneumonia in Adults

Business Wire January 22, 2015

Pfizer Provides Update on IBRANCE® (palbociclib)

Business Wire January 8, 2015

Nodality Launches PathPro(TM) Product Line Based on Leading Single Cell Network Profiling (SCNPTM) Platform to Enhance Pharmaceutical R&D

Business Wire January 7, 2015

Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

Business Wire January 6, 2015

Pfizer Acquires Redvax GmbH

Business Wire January 5, 2015

Pfizer Reports Top-Line Results From a Phase 3 Study Evaluating Pregabalin Controlled-Release Formulation as a Treatment for Patients With Postherpetic Neuralgia

Business Wire December 18, 2014

Pfizer Initiates Phase 2 Study of PF-06252616 in Duchenne Muscular Dystrophy

Business Wire December 17, 2014

Pfizer Invites Public to View and Listen to Webcast of January 27 Conference Call with Analysts

Business Wire December 16, 2014

Meningococcal Meningitis Survivor and TV Personality Amy Purdy and Pfizer Launch Take Action Against Meningitis

Business Wire December 16, 2014

Pfizer Announces Palbociclib PALOMA-1 Data Published in The Lancet Oncology

Business Wire December 15, 2014